{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:26Z","timestamp":1790621726467,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR063070"],"award-info":[{"award-number":["R01 AR063070"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR059947"],"award-info":[{"award-number":["R01 AR059947"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH"],"award-info":[{"award-number":["W81XWH"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EB Research Partnership"},{"DOI":"10.13039\/100002077","name":"EB Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002825","name":"DEBRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002825","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sohana Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/mt.2015.84","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T07:11:18Z","timestamp":1438326678000},"page":"1283-1284","source":"Crossref","is-referenced-by-count":2,"title":["From Mesoderm to Mesodermatology: Bone Marrow Mesenchymal Cells Heal Skin Wounds"],"prefix":"10.1016","volume":"23","author":[{"given":"Marketa","family":"Tolarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.84_bib1","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.84_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2015.84_bib3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2015.84_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2015.84_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.84_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","author":"Petrof","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.84_bib7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic eppidermolysis bullosa","volume":"23","author":"K\u00fchl","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.84_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jcyt.2015.03.006","article-title":"Placenta-based therapies for the treatment of epidermolysis bullosa","volume":"17","author":"Nevala-Plagemann","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2015.84_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02968135","article-title":"Ueber Entz\u00fcndung und Eiterung","volume":"40","author":"Cohnheim","year":"1867","journal-title":"Virch Arch Path Anat"},{"key":"10.1038\/mt.2015.84_bib10","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J Embryol Exp Morphol"},{"key":"10.1038\/mt.2015.84_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"10.1038\/mt.2015.84_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2015.03.001","article-title":"Mesenchymal stem cell exosomes","volume":"40","author":"Lai","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1038\/mt.2015.84_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2015.84_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2015.84_bib15","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.84_bib16","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","article-title":"Transplanted bone marrow\u2013derived circulating PDGFR\u03b1+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft","volume":"194","author":"Iinuma","year":"2015","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.84_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.84_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcibr1414709","article-title":"A biologic Velcro patch","volume":"372","author":"Tolar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.84_bib19","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T14:27:04Z","timestamp":1615386424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1525001616301630"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.84","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}